CRYSTAL WEBB: Open Payments
NPI 1861935918 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 63 payments from 15 companies in 2025. Trend: 2023 $760 · 2024 $1,114 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 22 | $332 |
| Xeris Pharmaceuticals, Inc. | 8 | $141 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $93 |
| Novo Nordisk Inc | 4 | $88 |
| Tandem Diabetes Care, Inc. | 6 | $70 |
| Alexion Pharmaceuticals, Inc. | 4 | $67 |
| TOLMAR, INC. | 4 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Sequel Med Tech, LLC | 2 | $34 |
Products named: Korlym, RECORLEV, ISTURISA, t:slim X2 Insulin Pump with Control-IQ, STRENSIQ, JATENZO, CRENESSITY, JARDIANCE.
Industry payments across IN — which companies pay providers there.
